Research on hyperbaric oxygen therapy (HBOT) as a treatment for long COVID has gained traction as scientists seek effective interventions for lingering symptoms experienced by many post-COVID patients. Studies have indicated that HBOT may help alleviate symptoms such as fatigue, cognitive dysfunction, and respiratory issues by enhancing oxygen delivery to tissues, reducing inflammation, and promoting healing. Early clinical trials have shown promising results, with participants reporting improvements in overall health and quality of life. While further research is needed to establish standardized protocols and long-term efficacy, HBOT represents a potentially valuable option for those grappling with the persistent effects of COVID-19.
